Recent Updates
Recently added Catalysts
HALO

Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Cowen and Company 34th Annual Healthcare Conference in Boston, MA on Tuesday,...

Key Takeaway: SAN DIEGO , Feb. 25, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the Cowen and Company 34 th Annual Healthcare Conference in Boston, MA on Tuesday, March 4, 2014 at 9:20 a.m. ET / 6:20 a.m. PT . David Ramsay , Chief Financial Officer, wi

Full Press Release Details

SAN DIEGO , Feb. 25, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the Cowen and Company 34 th Annual Healthcare Conference in Boston, MA on Tuesday, March 4, 2014 at 9:20 a.m. ET / 6:20 a.m. PT . David Ramsay , Chief Financial Officer, will provide a corporate overview.
The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com , and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately 15 minutes prior to the presentation to register and download any necessary audio software.
Investor Contact: Schond Greenway Halozyme Therapeutics 858-704-8352 [email protected]
Media Contact: Nurha Hindi Hill + Knowlton Strategies 310-633-9434 [email protected]
SOURCE Halozyme Therapeutics, Inc.

21 %

Last updated: Feb 25, 2014